Grape extract kills cancer cells

Grapes contain potentially beneficial chemicals that can destroy cancer cells, a new research proves.

Elekta gets ok from China

The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Avtalet med Almirall sägs upp

Index får tillbaka de europeiska rättigheterna för läkemedelskandidaten Kappaproct mot ulcerös kolit.

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

"Imponerande kraftsamling gav vaccin"

Det rekordsnabba framtagandet av nya vaccin under pandemin visar vad läkemedelsindustrin – och mänskligheten – kan åstadkomma när pressen är tillräckligt stor.

New CEO to Swedish Tillotts Pharma

The Swiss company Tillotts Pharma's newly established Swedish organisation has appointed a CEO from Bayer Scandinavia.

Samuel Lagercrantz: Samarbete och samverkan är nyckeln till framgång

Trots att många frågor om covid-19 fortfarande är obesvarade har utvecklingen av läkemedel och vaccin gått otroligt snabbt, skriver Samuel Lagercrantz i en ledare.

Hey Klementina Österberg ...

... CEO at GU Holding, which awards SEK 120, 000 to three female entrepreneurs.

Medtech companies find new beam technique

The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.

Samtycke från patient – i många fall inte tillräckligt för databehandling

Vilka är konsekvenserna av att den Europeiska dataskyddsstyrelsen uttalat att försökspersoner i de flesta fall inte kan samtycka till hantering av data rörande ...

New Nordic nutrition collaboration

Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.

Biden utser coronateam – hans rådgivare kritiserar Tegnell

USA:s nya president Joe Biden intar en helt ny hållning i bekämpningen av covid-19 än sin företrädare. Hans rådgivare Andy Slavitt kritiserade nyligen Anders Te...

Trio goes in for high tech medicines

The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.

Diagnostics to deal with new diseases

Maria Brytting at the Swedish Institute for Infectious Disease Control, SMI, will share her experiences from April 2009 when the new influenza A virus, H1N1, wa...

Biogaia's advance goes on

In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.

LEO Pharma - International Clinical Trial Manager

EUR 2 million for peanut allergies

ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.